BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-naamani N, Roberts KE. Portopulmonary Hypertension. Clinics in Chest Medicine 2013;34:719-37. [DOI: 10.1016/j.ccm.2013.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Günay N, Erdem Ş, Güvenç TS, Bulur A, Özdil K, Hasdemir H, Uyan C. Morphologic and Functional Changes in Right‐Sided Cardiac Chambers in Patients With Chronic Liver Disease and Normal Pulmonary Artery Pressure. J Ultrasound Med 2018;37:1681-91. [DOI: 10.1002/jum.14516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Liberal R, Grant CR, Baptista R, Macedo G. “Porto-pulmonary hypertension: a comprehensive review”. Clin Res Hepatol Gastroenterol. 2015;39:157-167. [PMID: 25659878 DOI: 10.1016/j.clinre.2014.12.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. J Heart Lung Transplant 2020;39:464-72. [PMID: 32008947 DOI: 10.1016/j.healun.2019.12.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]